Results 91 to 100 of about 20,667 (251)

Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD

International Journal of COPD, 2018
Yasushi Fukushima,1 Yuji Nakatani,2 Yumiko Ide,3 Hisakuni Sekino,4 Earl St Rose,5 Shahid Siddiqui,6 Andrea Maes,5 Colin Reisner5,6 1Department of Internal Medicine, Fukuwa Clinic, Tokyo, Japan; 2Department of Internal Medicine, Nakatani Hospital, Hyogo,
Fukushima Y, Nakatani Y, Ide Y, Sekino H, St Rose E, Siddiqui S, Maes A, Reisner C   +7 more
doaj  

Simultaneous liquid-chromatographic determination of some bronchodilators, anticonvulsants, chloramphenicol, and hypnotic agents, with Chromosorb P columns used for sample preparation. [PDF]

, 1989
Dobrin Svinarov, D C Dotchev
openalex   +1 more source

Efficacy of tiotropium and olodaterol combination therapy on dynamic lung hyperinflation evaluated by hyperventilation in COPD: an open-label, comparative before and after treatment study

International Journal of COPD, 2019
Shohei Kawachi,1 Keisaku Fujimoto21Department of Biomedical Laboratory Science, Graduate School of Medicine, Shinshu University, Nagano 390-8621, Japan; 2Department of Clinical Laboratory Sciences, Shinshu University School of Health Sciences, Matsumoto ...
Kawachi S, Fujimoto K
doaj  

Acute bronchodilator responses to β2-agonist and anticholinergic agent in COPD: Their different associations with exacerbation [PDF]

, 2017
Satoshi Konno, Hironi Makita, Masaru Suzuki, Kaoruko Shimizu, Hirokazu Kimura, Hiroki Kimura, Masaharu Nishimura   +6 more
openalex   +1 more source

Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD

International Journal of COPD, 2016
Peter M Calverley,1 Göran Eriksson,2 Christine R Jenkins,3 Antonio R Anzueto,4 Barry J Make,5 Anders Persson,6 Malin Fagerås,6 Dirkje S Postma7 1Pulmonary and Rehabilitation Research Group, University Hospital Aintree, Liverpool, UK ...
Calverley PM, Eriksson G, Jenkins CR, Anzueto AR, Make BJ, Persson A, Fagerås M, Postma DS   +7 more
doaj  

Cardiovascular morbidity and the use of inhaled bronchodilators

International Journal of COPD, 2008
Christine Macie, Kate Wooldrage, Jure Manfreda, Nicholas AnthonisenDepartment of Medicine, University of Manitoba, Winnipeg, Manitoba, CanadaAbstract: We used the Manitoba Health database to examine the relationship between use of inhaled respiratory ...
Christine Macie, Kate Wooldrage, Jure Manfreda, Nicholas Anthonisen   +3 more
doaj  

1702 At what age is ipratroprium bromide an effective bronchodilator agent in childhood asthma? [PDF]

, 1981
A. David Milner, I G Hodges, G M Stokes, R C Groggins   +3 more
openalex   +1 more source

The asthma : An advance on treatment and diagnosis. V. A treatment. 3. Bronchodilator agent ( entering on .BETA.2 adrenoceptor agonist).

, 1996
黒沢 元博, 五十嵐 康, 宮地 良樹   +2 more
openalex   +2 more sources

Reducing cholinergic constriction: the major reversible mechanism in COPD

European Respiratory Review, 2006
The airway narrowing in chronic obstructive pulmonary disease (COPD) has often been misunderstood as being irreversible. However, a large proportion of patients with COPD do respond to bronchodilator agents with significant changes in lung function ...
V. Brusasco
doaj  

Isolated porcine bronchi provide a reliable model for development of bronchodilator anti‐muscarinic agents for human use [PDF]

, 2008
Gianluigi D’Agostino, Anna Maria Condino, Luciana Gioglio, F Zonta, Marcello Tonini, Annalisa Barbieri   +5 more
openalex   +1 more source